Search
FDA is warning consumers not to purchase or use Intestinomicina, a drug marketed for infectious diarrhea, due to its containing unnaproved and dangerous ingredients. A quick Google search by PSM turned up several Spanish-language websites offering the drug for sale. This is a reprint of an FDA Alert. AUDIENCE: Consumer, Health Professional ISSUE: FDA is warning consumers not to use…
Read MoreRead the full comic here.
Read MoreThe Partnership for Safe Medicine’s Executive Director, Scott LaGanga, is presenting on Thursday September 20th, at the The PDMA Sharing Conference. The conference, held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland, is held over three days starting September 19th.
Mr. LaGanga will bring attendees up to date on the risks and dangers associated with counterfeit drugs, a real concern for American consumers.
Read MoreIn a recent interview with Pathogens & Global Health, Dr. Paul Newton, Head of the Welcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration in Vientiane, Laos, offered his expertise on the growing problem of counterfeit medication in the treatment of tropical diseases.
Dr. Paul Newton works in the heart of Malaria country in Southeast Asia. As a result, he has a very clear, first-hand perspective on the role counterfeit and substandard drugs play in drug resistance and the human cost of counterfeit medication. He is also well acquainted with the drug supply chain problems that plague malarious regions.
Read MoreNew Delhi, Monday, September 10, 2012: On September 10th, 2012, the first collaborative workshop was held organized by PSM India in collaboration with the Ministry of Health and Family Welfare, Government of India and World Health Organisation (WHO) India Country Office to demonstrate its commitment towards patient safety globally. More than 50 eminent experts participated representing countries from Europe, North…
Read MoreAbstract. Direct-to-consumer (DTC) advertising of suspect goods and services has burgeoned because of the Internet. Despite very limited approval for use, DTC stem cell–marketed “treatments” have emerged for an array of conditions, creating global public health and safety risks. However, it remains unclear whether such use of stem cells is subject to drugs or biologics regulations. To address this gap,…
Read MoreThe internet is a wild west of unregulated pharmaceutical websites, but Chinese and US cooperation are working together to make the Internet safer for consumers.
China Daily reports that US Food and Drug Administration agents working in China collaborated with the China Food and Drug Administration to shutter 18 Chinese-language websites illegally offering counterfeit drugs and health food for sale in the United States.
Read MoreClick on image to read The Greedy Doctor comic.
Read MoreThe new Director of the Food and Drug Administration’s (FDA) Office of Criminal
Investigations, John Roth, will be the luncheon speaker at the Partnership for Safe Medicines 2012 Interchange on September 28.
Roth joins the esteemed panel of Interchange speakers that includes keynote speaker Dr. Margaret Hamburg, Commissioner of the FDA, and panelists Gerald Heddell, Director of Inspection, Enforcement and Standards of the UK’s MHRA, and James Dinkins, Executive Associate Director, ICE’s Homeland Security Investigations.
Read More